Literature DB >> 20121558

Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders.

A George Awad.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20121558     DOI: 10.1586/erp.10.2

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


× No keyword cloud information.
  5 in total

Review 1.  Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.

Authors:  A George Awad
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

Review 2.  The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

3.  Newer Antiepileptic Drugs Discontinuation due to Adverse Effects: An Observational Study.

Authors:  Mehdi Golpayegani; Farhad Salari; Kurosh Gharagozli
Journal:  Ann Indian Acad Neurol       Date:  2019 Jan-Mar       Impact factor: 1.383

4.  Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.

Authors:  George Awad; Mariam Hassan; Antony Loebel; Jay Hsu; Andrei Pikalov; Krithika Rajagopalan
Journal:  BMC Psychiatry       Date:  2014-02-23       Impact factor: 3.630

5.  Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study.

Authors:  Xia Zhou; Xiaolan Wang; Rui Li; Jun Yan; Ying Xiao; Weiguang Li; Hong Shen
Journal:  Front Psychiatry       Date:  2020-10-30       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.